Release of biologically active substances from non-aggregating human platelets
- 1 May 1982
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 80 (2-3) , 203-207
- https://doi.org/10.1016/0014-2999(82)90055-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Release of endogenous noradrenaline and 5-hydroxytryptamine from human blood platelets by thrombinJournal of Pharmacy and Pharmacology, 1981
- 6-keto-prostaglandin E1 inhibits the aggregation of human plateletsEuropean Journal of Pharmacology, 1979
- DIFFERENTIAL INHIBITION OF PROSTACYCLIN PRODUCTION AND PLATELET AGGREGATION BY ASPIRINThe Lancet, 1979
- Hypotensive and renovascular actions of 6-keto-prostaglandin E1, a metabolite of prostacyclinEuropean Journal of Pharmacology, 1979
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- PATHWAYS OF PROSTAGLANDIN F2α METABOLISM IN MAMMALIAN KIDNEYSBritish Journal of Pharmacology, 1977
- Radioimmunoassay of prostaglandins E1, E2, and F2α in unextracted plasma, serum and myocardiumProstaglandins, 1976
- Human blood prostaglandins: Formation during clottingProstaglandins, 1972
- Extraction of Prostaglandins from Human BloodNature, 1971
- Adenosine Diphosphate in Red Cells as a Factor in the Adhesiveness of Human Blood PlateletsNature, 1961